title: Peritoneal cultures and antibiotic therapy in pediatric perforated appendicitis.
abstract: We retrospectively reviewed 70 cases of perforated appendicitis in children to examine the relationship between postoperative antibiotic selection and culture results from the peritoneal cavity. Initial antibiotic therapy chosen for the children consisted of a three-drug combination in 54 (77%) patients. Peritoneal cultures were performed in 58 (83%) patients. Escherichia coli and Bacteriodes fragilis were the most common bacterial isolates from the peritoneal culture. Only 7 (10%) patients had their antibiotic regimen changed after the culture results were available, of which 2 changes brought drug therapy into compliance with the cultures and 5 changes were inappropriate with respect to the peritoneal cultures. Of the remaining 51 patients with culture data available, 39 should have had changes to bring the antibiotic therapy into compliance with the observed culture results. These data indicate that surgeons select antibiotic therapy for perforated appendicitis in children based on assumptions of which organisms should be present in the infection and not on culture data. There appears to be no clinical usefulness to the routine culturing of the peritoneal cavity in children with perforated appendicitis.
authors.affiliation: Department of Surgery, University of New Mexico School of Medicine, Albuquerque 87131.
authors.forename: D M
authors.initials: DM
authors.lastname: Mosdell
authors.forename: D M
authors.initials: DM
authors.lastname: Morris
authors.forename: D E
authors.initials: DE
authors.lastname: Fry
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001062:Appendectomy; D001064:Appendicitis / Q000150:complications / Q000382:microbiology* / Q000628:therapy*; D001441:Bacteroides fragilis / Q000302:isolation & purification; D002648:Child; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D006801:Humans; D007416:Intestinal Perforation / Q000150:complications / Q000382:microbiology* / Q000628:therapy*; D007432:Intraoperative Period; D008297:Male; D010529:Peritoneal Cavity / Q000382:microbiology*; D010538:Peritonitis / Q000188:drug therapy / Q000209:etiology / Q000517:prevention & control; D011182:Postoperative Care; D012189:Retrospective Studies; D012422:Rupture, Spontaneous
chemical_list: D000900:Anti-Bacterial Agents